MassARRAY multigene screening combined with LDL-C and sdLDL-C detection for more favorable outcomes in type 2 diabetes mellitus therapy

BACKGROUND: To determine the clinical value of multigene polymorphisms, LDL-C and sdLDL-C on T2DM therapy. METHODS: In total, 352 T2DM patients before and after treatment and 48 healthy individuals were enrolled in this study. LDL-C and sdLDL-C were detected in 352 T2DM patients and 48 healthy indiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yong, Wang, Junhong, Liu, Yanxiao, Luo, Xiangguang, Yao, Ziying, Wang, Xinjun, Zhang, Yuanyuan, Xu, Cheng, Zhao, Xiaoyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972339/
https://www.ncbi.nlm.nih.gov/pubmed/33731122
http://dx.doi.org/10.1186/s12920-021-00937-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972339/
https://www.ncbi.nlm.nih.gov/pubmed/33731122
http://dx.doi.org/10.1186/s12920-021-00937-8

Ejemplares similares